Indication: Prostate Cancer
A Phase 1b Study Evaluating the Safety and Efficacy of Multiple Therapies in Subjects With Metastatic Castration Resistant Prostate Cancer
Sub-indication: Genitourinary Cancer
Study Type: Drug Study
Principal Investigator: Joseph Maly, M.D.Norton Cancer Institute
Sponsor: Sponsor: Amgen
Learn more at ClinicalTrials.gov
Email for more information: MISC-NCIResearch@nortonhealthcare.org
